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Individual’s hearing performance after cochlear implant (CI) is variable and depends on different factors such as etiology of
deafness, age at implantation, and social/family hearing environment. Here we report the case of dizygotic twins, boy and girl,
presenting with neurosensorial profound deafness prior CI (age of implantation = 3.5 years old). Both parents have severe/pro-
found deafness, since childhood, and use sign language as primary mode of communication. Clinical and genetic characterization
was performed, as well as the assessment of the auditory and oral (re)habilitation after CI, applying a battery of audiological,
speech, and language tests. The twin girl and the father were homozygous for the c.35delG mutation in the GJB2 gene, while the
twin boy and the mother were compound heterozygotes, both monoallelic for c.35delG and for the deletion del(GJB6-D13S1830)
in the GJB6 gene. The remaining hearing impaired relatives were c.35delG homozygotes. The genetic cause of deafness was thus
identified in this family. Some noteworthy differences were observed regarding twins’ auditory and oral performance after CI.
Subsequent follow-up of these children allowed us to conclude that those differences were most likely due to the different environ-
ment in which the twins have been living than to their different GJB2/GJB6 genotypes.
1. Introduction
After cochlear implantation (CI) the individual’s hearing
performance will vary according to their age at implantation
[1], duration of implant use [2], level of residual hearing and
mode of communication [3]. However, it has been doc-
umented that the contribution of these factors to speech
perception after CI explains less than 50% of the variability
observed [4], the remaining being related to other factors.
One of these factors is thought to be the etiology of deafness
[2, 5, 6], namely, connexin-associated deafness [7].
DFNB1 locus was the first nonsyndromic autosomal
recessive deafness-related locus to be identified and is located
on chromosome 13q11 [8]. It includes GJB2 and GJB6 genes,
enconding the gap junction beta-2 protein (connexin 26) and
the gap junction beta-6 protein (conexin 30), respectively.
Mutations in the GJB2 gene are the most frequent in non-
syndromic recessive deafness, accounting for up to 50% of
the cases [9]. The c.35delG mutation, a deletion of a guanine
in the GJB2 coding sequence, is the most common recessive
deafness-causing mutation in Europe. Two large deletions,
del(GJB6-D13S1830) and del(GJB6-D13S1854), identified in
the GJB6 gene, are often found in double heterozygosity with
mutations in GJB2, which is thought to result in loss of func-
tion of the connexin cluster [10]. Most of these genotypes
originate severe to profound congenital deafness, which are
the cases recommended for cochlear implantation.
This study aimed at performing clinical and genetic char-
acterization, as well as evaluating the oral (re)habilitation, of
two nonidentical twins with cochlear implant.
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Table 1: Clinical history of the twins.
ICC088 (III : 7) ICC089 (III : 6)
Gender Female Male
Deafness etiology Congenital Congenital
Suspicion of deafness 18 months 18 months




No previous surgical procedures
2 episodes of ear infections (otitis) prior
implantation (without suppuration)
No allergies
Vaccination plan up to date
Normal pregnancy
No associated pathologies
No previous surgical procedures
No allergies
Vaccination plan up to date
Audiogram
Neurosensorial bilateral profound deafness,
stage 3
Neurosensorial bilateral profound deafness,
stage 3
Placement of hearing aids 24 months 24 months




Functional gain up to 1000 Hz
No language development
Auditory evoked potentials (AEP)
Wave V present above 90 dB nHL on the right
and above 100 dB nHL on the left
Absence of AEPs until 110 dB nHL bilaterally
Computerized axial tomography scan
(CAT scan)
Morphologically normal and permeable cochlea
Normal inner ear canals
Morphologically normal and permeable cochlea
Normal inner ear canals
Magnetic resonance imaging (MRI)
No morphological alterations
No congenital malformations




No cochlear nerve atrophy
Normal cochleas
Age at implantation 42 months 42 months
Duration of CI use 56 months 56 months
Age at audiological tests and present
study
8 years 8 years
CI model CI24R CA Advance CI24R CA Advance
Speech processor SPRINT SPRINT
Stimulation mode MP1+2 MP1+2
Stimulation strategy ACE ACE









Figure 1: Family pedigree. Affected relatives are in full colour, the arrows signal the twins.
2. Patient Presentation
We report the case of dizygotic twins (a boy and a girl), aged 8
years, both with cochlear implants (CI). Both twins (Figure 1:
ICC88, III : 7 and ICC89, III : 6) presented with neurosen-
sorial profound hearing loss prior to implantation. Their
parents (Figure 1: ICC88A, II : 9 and ICC88B, II : 8) are also
severely to profoundly hearing impaired since childhood, use
sign language as primary mode of communication, and have
one unaffected daughter each, from a prior marriage, as well
as several affected and unaffected relatives.
Table 1 presents the clinical history of the twins. It can
be observed that both of them were diagnosed, started using
hearing aids, and received their cochlear implant at the same







































































































Figure 2: Electrophoresis results. (a) Enzymatic restriction with
BslI for identification of c.35delG mutation according to Storm et al.
[11]. Gama frg: internal restriction control (153bp band); Und Ctr:
undigested restriction control (209 bp and 153 bp bands); c.35delG
Ctr: c.35delG homozygous control (186 bp band). Homozygous
mutated individuals present only the 186 bp band and heterozygous
individuals present both the 209 bp and 186 bp bands. (b) PCR
multiplex for identification of del(GJB6-D13S1830) and del(GJB6-
D13S1854) according to del Castillo et al. [10]. Del 1854: heterozy-
gous control for del(GJB6-D13S1854); Del 1830: heterozygous con-
trol for del(GJB6-D13S1830). The 333 bp band corresponds to non-
mutated allele, the 460 bp band to del(GJB6-D13S1830) mutated
allele and 564 bp band to del(GJB6-D13S1854) mutated allele.
time. Likewise, they use the same CI model with the same
characteristics.
Written informed consent was obtained from all individ-
uals and the study was approved by the Ethical Commission
of the Hospital.
DNA from the two twins and from affected and unaf-
fected relatives was analysed, by sequencing and multiplex
PCR, in respect to the presence of GJB2 coding mutations
and GJB6 deletions (del(GJB6-D13S1830) and del(GJB6-
D13S1854)). Molecular analysis revealed that the twins
present different genotypes: the girl (ICC088, III : 7) is
homozygous for the c.35delG autosomal recessive mutation
in GJB2 while the boy (ICC089, III : 6) is a compound hetero-
zygote for the c.35delG mutation and the GJB6 large deletion
del(GJB6-D13S1830) (Figure 2). Both genotypes are associ-
ated with severe congenital deafness phenotype. This genetic
evaluation was included in a broader study involving DFNB1
genotype-phenotype correlation in Portuguese CI individu-
als [7], being the first time that del(GJB6-D13S1830) deletion
was found in Portuguese deaf patients.
The different genotypes of the twins justified the genetic
analysis of some of the twins’ relatives (Figure 2). The father
(ICC088B, II : 8) is a c.35delG homozygote, as the twin girl,
and the mother (ICC088A, II : 9) is a c.35delG/del(GJB6-
D13S1830) compound heterozygote like the twin boy.
Accordingly, the affected relatives from the father’s side
(ICC088E, II : 5 and ICC088F, III : 6) are c.35delG homo-
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Figure 3: Pure-tone threshold levels of the twins after cochlear













































Figure 4: Twins speech perception tests results (taken in 2009, 5
years of implant use). Disyllabic words test discrimination score,
Monosyllable test, Monosyllable phoneme test, Number test, Num-
ber phoneme test, and Phrases: sentences test.
(ICC088C, I : 2 and ICC088D, II : 3) or none (ICC088G,
II : 4) c.35delG alleles. None of them presented the GJB6
deletion. On the mother’s side no relative has been studied.
Assessment of the twins’ global auditory and oral per-
formance after cochlear implantation was carried out by
applying a battery of audiological, speech, and language
tests at the ENT Department from the Centro Hospitalar de
Coimbra such as disyllabic words test discrimination score,
monosyllable test, monosyllable phoneme test, number test,
number phoneme test, sentences test, categories auditory
performance (CAP), closed-set word perception test (with
real objects, images, or written words), verbal articulation
test (evaluates 19 consonants and 3 consonant groups, cal-
culated as percentage of phonemes correctly produced),


















































































Figure 5: Twins’ audiological test results in the last three years. (a) CAP: Categories Auditory Performance; (b) TPP: closed-set word
perception test; (c) Articulation: verbal articulation test; (d) Vowels: percentage of accurate vowels; (e) GACV: Vocal characteristics test
(voice intensity, pitch, nasal resonance, intonation and breathing, etc.); (f) SIR: Speech Intelligibility Ratting.
percentage of accurate vowels, vocal characteristics test (voice
intensity, pitch, nasal resonance, intonation and breathing,
phonation and articulation coordination), and speech intel-
ligibility rating (SIR).
When observing the twins’ audiograms at 3.5 years old,
just after CI, (Figure 3), the pure tone thresholds for most
frequencies were very similar. Thus, it would be reasonable
to assume their auditory and oral performance scores would
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also be similar. However the speech perception tests per-
formed after 5 years of CI use (Figure 4), show that the
twin girl (ICC88, III : 7) had an overall good performance
throughout the tests while the twin boy (ICC89, III : 6) got
poorer results, had difficulties regarding some of the age
appropriate tests that are part of the standard evaluation, and
was not even able to respond to some of the tests.
Could the differences in auditory and oral outcomes
on post-CI rehabilitation be related to the different DFNB1
genotypes? Further analysis of the family history showed that
other factors could be playing an important role and con-
tributing for the differences observed. The twins had not
lived together in the same hearing environment as previously
assumed. On the contrary, each of them came from a differ-
ent social background. The twin girl has lived since she was 6
months-old with their hearing aunt, and uncle (II : 1 and
II : 2) and has been educated in a regular school with special
education and speech therapy while the twin boy lived until 7
years-old with the hearing impaired parents, who only used
sign language as mode of communication, thus in a poor
auditory stimulating environment, only having contact with
other deaf children, and with some household problems. In
2009, through legal decision, he moved in with his sister, aunt
and uncle (II : 1 and II : 2) and integrated regular school with
special education and speech therapy. The audiological tests
from the last three years revealed the twin boy’s favourable
evolution since this social alteration (Figure 5). The positive
effect of the auditory and oral stimulation observed in the
twin since he moved to his aunt highlights the importance
of the auditory stimulating environment in the success of the
post-CI rehabilitation.
3. Conclusion
The nonidentical twins here analysed, aged 8 years-old
presented different genotypes, c.[35delG]+[35delG] and
[c.35delG]+[del(GJB6-D13S1830)], and different speech
perception results after CI. The twin boy presented weaker
verbal outcomes and worse level of residual hearing before
he was implanted (absence of AEP’s). However, both twins’
audiograms were very alike after CI, revealing that their hear-
ing thresholds, unlike their auditory and oral performance,
were similar.
As such, the observed differences in the oral performance
are most likely due to the different social context in which the
twins have been living and not to their different GJB2/GJB6
genotype. The oral outcome of the twin boy improved from
the moment he started living in a hearing stimulating envi-
ronment, which is a strong evidence of this factor’s impor-
tance in the success of the oral rehabilitation after CI, namely,
in DFNB1-associated hearing loss cases.
The remaining twins’ affected relatives studied carried
the c.35delG mutation in homozigosity. Molecular diagnosis
and genetic counselling is thus very important to a family
such as this one, namely, to the twins’ unaffected half-sister
still alive.
Acknowledgments
The authors would like to thank the family for their con-
tribution to the investigation. The present study was finan-
cially supported by Cochlear.
References
[1] M. Manrique, F. J. Cervera-Paz, A. Huarte, and M. Molina,
“Advantages of cochlear implantation in prelingual deaf chil-
dren before 2 years of age when compared with later implan-
tation,” Laryngoscope, vol. 114, no. 8, pp. 1462–1469, 2004.
[2] S. S. Connell, S. I. Angeli, H. Suarez, A. V. Hodges, T. J.
Balkany, and X. Z. Liu, “Performance after cochlear implanta-
tion in DFNB1 patients,” Otolaryngology, vol. 137, no. 4, pp.
596–602, 2007.
[3] R. Taitelbaum-Swead, Z. Brownstein, C. Muchnik et al.,
“Connexin-associated deafness and speech perception out-
come of cochlear implantation,” Archives of Otolaryngology,
vol. 132, no. 5, pp. 495–500, 2006.
[4] G. M. Clark, R. K. Shepherd, and C. G. Treaba, “Peri-modiolar
electrode arrays: a comparison of electrode position in the
human temporal bone,” in Cochlear Implants: XVI World
Congress of Otorhinolaryngology Head and Neck Surgery, pp.
205–209, Monduzzi Editore, Bologna, Italy, 1997.
[5] C. C. Morton and W. E. Nance, “Newborn hearing screen-
ing—a silent revolution,” New England Journal of Medicine,
vol. 354, no. 20, pp. 2151–2164, 2006.
[6] T. V. Christiani, F. Alexandrino, C. A. De Oliveira et al.,
“Molecular study in Brazilian cochlear implant recipients,”
American Journal of Medical Genetics, Part A, vol. 143, no. 14,
pp. 1580–1582, 2007.
[7] J. R. G. D. B. M. Chora, T. D. M. Matos, J. H. F. Martins et al.,
“DFNB1-associated deafness in Portuguese cochlear implant
users: prevalence and impact on oral outcome,” International
Journal of Pediatric Otorhinolaryngology, vol. 74, no. 10, pp.
1135–1139, 2010.
[8] P. Guilford, S. B. Arab, S. Blanchard et al., “A non-syndromic
form of neurosensory, recessive deafness maps to the pericen-
tromeric region of chromosome 13q,” Nature Genetics, vol. 6,
no. 1, pp. 24–28, 1994.
[9] R. L. Snoeckx, P. L. M. Huygen, D. Feldman, S. Marlin, F.
Denoyelle, J. Waligora et al., “GJB2 mutations and degree of
hearing loss: a multicenter study,” The American Journal of
Human Genetics, vol. 77, pp. 945–957, 2005.
[10] F. J. Del Castillo, M. Rodrı́guez-Ballesteros, A. Álvarez et al.,
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